An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

Frank O. Nestlé, Selma Alijagic, Michel Gilliet et al. · Nature Medicine · 1998 · 2.9K citations

Medicine, Immunology, Oncology +14

Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

Beatrice Thurner, Ina Haendle, Claudia Röder et al. · The Journal of Experimental Medicine · 1999 · 1.2K citations · Full text

Medicine, Immunology, Oncology +17

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

John W. Shiver, Tong‐Ming Fu, Ling Chen et al. · Nature · 2002 · 1.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +10

Immune responses to adenovirus and adeno-associated virus in humans

Narendra Chirmule, Kathleen J. Propert, Susan Magosin et al. · Gene Therapy · 1999 · 681 citations

Life Sciences, Immunology, Infectious Diseases +14

The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F

Peter W. Roelvink, Alena Lizonová, Jennifer G. M. Lee et al. · Journal of Virology · 1998 · 646 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +6